Creative Medical Technology Holdings Expands Neurological Application of ImmCelz® into Parkinson’s Disease
- Monday, May 24, 2021, 7:16
- PR Newswire
- Add a comment
PHOENIX, May 24, 2021 /PRNewswire/ — Creative Medical Technology Holdings, trading under ticker symbol CELZ, announced today positive preclinical data supporting extension of ImmCelz® applicability to Parkinson’s Disease. Using the well established MPTP mouse model of the disease, it was…
About the Author
admin has written 20652 stories on this site.